Landscapes / Targets
FRα
11 drugs act on FRα, in 21 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs11
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
AbbVie · Public ABBV |
Approved | Nov 2026soonPhase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Fallopian Tube Cancer, Primary Peritoneal Cancer and 9 more | ||||
| Open drug page | |||||
— |
Approved | 28 May 2027Phase 4 trial completes | |||
| Next date | 28 May 2027 · Phase 4 trial completes | ||||
| Also tested for | Cancer in the Lung, Ovarian Cancer | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
AstraZeneca · Public AZN |
Phase 3 | 4 Aug 2028Phase 1/2 trial completes | ||
| How it works | An antibody | ||||
| Next date | 4 Aug 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Ovarian Cancer, Epithelial Ovarian Cancer and 8 more | ||||
| Open drug page | |||||
— |
CSPC · Public 1093.HK |
Phase 2 | 28 Mar 2027Phase 1/2 trial completes | ||
| Next date | 28 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Ovarian Cancer, Recurrent Ovarian Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Sep 2029Phase 1/2 trial completes | |||
| Next date | Sep 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Ovarian Cancer | ||||
| Open drug page | |||||
Monoclonal antibody |
Phase 1/2 | 8 Aug 2030Phase 1/2 trial completes | |||
| How it works | An antibody | ||||
| Next date | 8 Aug 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Ovarian Cancer, Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Mar 2028Phase 1 trial completes | |||
| Next date | Mar 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2029Phase 1 trial completes | |||
| Next date | Jan 2029 · Phase 1 trial completes | ||||
| Also tested for | Pancreatic Ductal Adenocarcinoma (PDAC), Advanced Solid Tumor Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Ovarian Cancer, Platinum-resistant Ovarian Cancer and 4 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 11 of 11 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026